We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$132M
AUM Growth
$0
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
46.58%
Holding
34
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 81.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$19.2M 14.55%
150,000
– –
CAH icon
2
Cardinal Health
CAH
$52.9B
$5.07M 3.85%
24,000
– –
JNJ icon
3
Johnson & Johnson
JNJ
$599B
$4.89M 3.71%
20,000
– –
MRK icon
4
Merck
MRK
$307B
$4.81M 3.65%
40,000
– –
COR icon
5
Cencora
COR
$59.1B
$4.71M 3.58%
15,000
– –
LLY icon
6
Eli Lilly
LLY
$1.02T
$4.6M 3.49%
5,000
– –
WAT icon
7
Waters Corp
WAT
$35.1B
$4.47M 3.39%
15,000
– –
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$122B
$4.46M 3.39%
10,000
– –
ISRG icon
9
Intuitive Surgical
ISRG
$125B
$4.15M 3.15%
9,000
– –
AZN icon
10
AstraZeneca
AZN
$255B
$3.94M 3%
20,000
– –
TMO icon
11
Thermo Fisher Scientific
TMO
$196B
$3.93M 2.99%
8,000
– –
BSX icon
12
Boston Scientific
BSX
$65.1B
$3.89M 2.95%
62,000
– –
DHR icon
13
Danaher
DHR
$142B
$3.79M 2.88%
20,000
– –
THC icon
14
Tenet Healthcare
THC
$16.7B
$3.77M 2.87%
20,000
– –
GILD icon
15
Gilead Sciences
GILD
$165B
$3.48M 2.65%
25,000
– –
HUM icon
16
Humana
HUM
$47.8B
$3.47M 2.63%
20,000
– –
MTD icon
17
Mettler-Toledo International
MTD
$25.7B
$3.47M 2.63%
2,750
– –
MCK icon
18
McKesson
MCK
$97.3B
$3.46M 2.63%
4,000
– –
A icon
19
Agilent Technologies
A
$36.8B
$3.42M 2.6%
30,000
– –
SYK icon
20
Stryker
SYK
$122B
$3.29M 2.5%
10,000
– –
ABBV icon
21
AbbVie
ABBV
$448B
$3.26M 2.48%
15,000
– –
UHS icon
22
Universal Health Services
UHS
$9.12B
$3.13M 2.38%
17,500
– –
REGN icon
23
Regeneron Pharmaceuticals
REGN
$70.5B
$3.09M 2.35%
4,000
– –
BIO icon
24
Bio-Rad Laboratories Class A
BIO
$8.08B
$2.79M 2.12%
10,000
– –
BIIB icon
25
Biogen
BIIB
$29.5B
$2.75M 2.09%
15,000
– –
1
2

Similar funds

RYA
Richard Young Associates Augusta, Georgia $132M AUM
RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
RWA
Reicon Wealth Advisors Atlanta, Georgia $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM

Sivik Global Healthcare's Q2 2026 Portfolio in Review

As of Q2 2026, Sivik Global Healthcare held 34 positions worth $132M, unchanged from the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. Sivik Global Healthcare opened no new positions and made no exits, leaving the 34-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, unchanged from a quarter earlier.

  • Sivik Global Healthcare's ten largest holdings make up 47% of its $132M portfolio in Q2 2026.
  • Sivik Global Healthcare opened 0 new positions and closed 0 in Q2 2026.
  • Sivik Global Healthcare's portfolio value was unchanged quarter-over-quarter at $132M.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.